what are the newest drugs and treatments for relapsed and refractory myeloma?
Published 4 years ago • 238 plays • Length 3:25Download video MP4
Download video MP3
Similar videos
-
4:41
defining relapsed and refractory myeloma; what's the difference?
-
2:14
what are the treatment options for relapsed/refractory myeloma?
-
1:02:15
when and how you become refractory to a drug and how to find the best next treatment
-
4:03
what are the main classes of drugs used in myeloma?
-
41:11
multiple myeloma: what new patients need to know | the patient story
-
1:03:25
the lenalidomide patch for myeloma: what do we know?
-
6:36
why is it important to be consulting with a myeloma specialist at relapse? #myeloma
-
1:07
with relapsed myeloma, when should you modifying current therapy or start a new therapy?
-
19:36
new horizons in the treatment of relapsed and refractory myeloma
-
6:20
what are the most common myeloma drug regimens for induction therapy?
-
5:08
what is relapsed and refractory myeloma? | experts explain #myeloma
-
9:50
treatment for relapsed and refractory multiple myeloma
-
17:13
all about revlimid (lenalidomide)
-
8:26
ash 2018: selinexor, daratumumab and dexamethasone for relapsed/refractory myeloma
-
4:59
biochemical vs. clinical relapse, and when you need treatment
-
1:59
optimal treatment sequencing for relapsed/refractory myeloma
-
2:22
recent drug approvals for the treatment of relapsed/refractory multiple myeloma
-
10:54
stockholm 2018: new drugs in multiple myeloma
-
15:53
new horizons in the treatment of relapsed and refractory myeloma
-
4:25
what new drug options will be available for patients with relapsed and refractory myeloma in 2020?
-
52:35
what's next? decision-making for relapsed/refractory myeloma | mcrt webcast march 20, 2021